| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 43 | 16.7x | 17.8x | Around median | |
Growth | 66 | 15.0% | 7.1% | Around median | |
Quality | 64 | 8.6% | 4.5% | Around median | |
Safety | 63 | 3.1x | 2.6x | Around median | |
Capital Return | 71 | 5.70% | 2.12% | Top tier | |
Momentum | 63 | 14.8% | 2.9% | Around median | |
Sentiment | 72 | 5 | 3 | Top tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Omega Healthcare Investors (OHI) is a real estate investment trust focused on skilled nursing facilities, senior housing, and care homes in the United States and the United Kingdom. It generates income through triple-net lease structures and real estate loans, while expanding its SHOP operating portfolio and RIDEA structures, which give it a larger share of operating cash flows. The portfolio has evolved from almost complete exposure to skilled nursing facilities in 2001 to a mix that includes senior housing and UK care homes, while Saber has become the largest operator among the top ten operators, and PACS and the UK GoldCare portfolio have entered the list.
In fiscal Q2 2026, revenue rose to $328 million from $283 million in the comparable period, supported by new investments completed during 2025 and 2026, annual rent escalators, and portfolio management. Net income available to common shareholders reached $363 million, or $1.19 per share, compared with $137 million and $0.46 per share, but the result included a $247 million gain from asset sales, particularly the sale of 18 facilities from the CommuniCare portfolio. Therefore, operating cash flow metrics were more conservative, with adjusted AFFO of $261 million, or $0.83 per share, and FAD of approximately $248 million, or $0.78 per share.
Fiscal 2025 revenue was approximately $1.2 billion, net income was $590.2 million, and earnings per share were $1.94, while the latest trailing twelve-month data recorded revenue of approximately $1.3 billion, net income of $858.4 million, and earnings per share of approximately $2.71. The provided data does not include a gross margin figure, and fiscal Q2 2026 net income exceeding revenue reflects the large gain from asset sales and does not represent a repeatable operating margin. In terms of mix, Omega continues to combine its triple-net lease portfolio with its growing SHOP portfolio and RIDEA investments, while expanding across skilled nursing facilities, senior housing, and UK care homes.
The analyst consensus on OHI is “Neutral,” with an average price target of $50.57 and a range of $47 to $56. The average target is below the 52-week range high of $52.39, while the highest target exceeds that high and the lowest target remains within the annual range of $39.26–$52.39, reflecting differing views on the pace of capital redeployment and the RIDEA transition. A usable price-to-earnings ratio is not available in the data, and the $247 million gain from asset sales should be separated from operating earnings when estimating value.
Figures in the text are as of 2026-08-29; the live price is shown at the top of the page.
Revenue reached $328 million, compared with $283 million in the comparable period, due to new investments, annual rent escalators, and portfolio management. Net income available to common shareholders was $363 million, or $1.19 per share. Net income included a $247 million gain from asset sales, so adjusted AFFO of $261 million and FAD of $248 million were more relevant measures of recurring performance.
Omega raised and narrowed its adjusted AFFO range to $3.22–$3.26 per share from $3.19–$3.25. The midpoint increased to $3.24 per share, up $0.02 from its April 2026 guidance. The guidance includes investments completed through July 29, 2026, but does not include additional investments not specified in the earnings release.
Omega completed the sale of 18 CommuniCare facilities in Maryland and West Virginia for a contractual price of $480 million, as part of broader asset sales that generated a $247 million gain in fiscal Q2 2026. Proceeds from asset sales and loan repayments, totaling approximately $700 million, helped reduce borrowings under the credit facility to $6 million. The company also holds approximately $118 million of sale proceeds with qualified intermediaries to fund investments through a 1031 exchange, with redeployment expected into higher-yielding transactions.
Automated analysis for informational purposes only — not investment advice.
Omega acquired the operations of four care homes it owns in the United Kingdom for $20 million and converted them into the company’s first UK RIDEA investment. Management expects stabilized yields in the low-to-mid double digits for RIDEA transactions, compared with the low double digits for triple-net transactions. The opportunity pipeline in the United States and the United Kingdom includes a significant RIDEA component, giving Omega greater exposure to occupancy, margin, and cash flow growth, while also assuming higher operating risk.
Asset sales of $597 million and loan repayments of $209 million over two quarters reduced fiscal Q2 2026 AFFO by $7.5 million, and the timing impact is expected to continue in fiscal Q3 2026. Omega is also awaiting repayment of approximately $148 million of Genesis loans when the bankruptcy process, expected by the end of fiscal 2026, concludes. In addition, RIDEA expansion increases direct exposure to occupancy and margins, while Medicaid rates and state budget pressures remain regulatory factors to monitor.
